Dr. Fred Moll and Vitestro CEO Toon Overbeeke Sonder Capital co-led the $22 million investment in Vitestro to ramp up production and commercialization. UTRECHT, The Netherlands, April 30, 2024 (GLOBE ...

Vitestro has raised $70m to advance development and broaden the commercialisation of its autonomous blood-drawing robot. The Dutch company's oversubscribed Series B financing round saw a mix of ...

UTRECHT, Netherlands, Aug. 28, 2024 /PRNewswire/ -- Vitestro, a pioneer in the field of medical robotics, is proud to announce that its innovative automated blood drawing device has received CE ...

Utrecht-based Vitestro has raised €20mn to bring its robotic blood drawing device to market. Founded in 2017, Vitestro aims to improve the blood draw experience for patients and address personnel ...

Blood draws are one of the most common invasive medical procedures in the world, yet little has changed about how we do them: for centuries, it’s involved one human sticking another with a needle – ...

In future, blood samples may be taken by an autonomous robot rather than a healthcare professional – if Dutch developer Vitestro can get its prototype approved for marketing. Vitestro's blood drawing ...

Netherlands-based medical robotics company Vitestro has unveiled Aletta, claimed to be the “world's first” Autonomous Robotic Phlebotomy Device (ARPD), designed for blood collection. Named after the ...

for its autonomous blood drawing device, with enrolment of first patients in A.D.O.P.T. Utrecht, The Netherlands, 6 September 2023 – Vitestro, expert in medical robotics, has launched the A.D.O.P.T.